Bittoo Kanwar

2.4k total citations
31 papers, 1.8k citations indexed

About

Bittoo Kanwar is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Bittoo Kanwar has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Immunology and 10 papers in Hepatology. Recurrent topics in Bittoo Kanwar's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Bittoo Kanwar is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Bittoo Kanwar collaborates with scholars based in United States, Canada and Germany. Bittoo Kanwar's co-authors include Joseph M. McCune, David Favre, Jeff E. Mold, Jason D. Barbour, P’ng Loke, Margaret M. Lowe, Yong Huang, Sean Proll, Carole R. Baskin and Michael G. Katze and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Bittoo Kanwar

31 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bittoo Kanwar United States 17 673 630 533 398 348 31 1.8k
Sara Ferrando‐Martínez Spain 25 660 1.0× 741 1.2× 463 0.9× 558 1.4× 402 1.2× 67 1.8k
Isabelle Garrigue France 24 501 0.7× 381 0.6× 925 1.7× 435 1.1× 137 0.4× 56 1.7k
Gene M. Shearer United States 18 1.6k 2.3× 1.5k 2.4× 781 1.5× 687 1.7× 196 0.6× 25 2.7k
Giuseppe Nunnari Italy 26 643 1.0× 1.1k 1.8× 573 1.1× 726 1.8× 375 1.1× 58 2.2k
M. Leal Spain 24 318 0.5× 628 1.0× 674 1.3× 599 1.5× 320 0.9× 77 1.8k
Alejandro Vallejo Spain 20 417 0.6× 744 1.2× 368 0.7× 766 1.9× 383 1.1× 101 1.7k
Cara C. Wilson United States 32 1.5k 2.3× 1.6k 2.6× 633 1.2× 804 2.0× 788 2.3× 57 2.9k
Barry M. Bredt United States 19 844 1.3× 1.2k 1.8× 954 1.8× 758 1.9× 214 0.6× 21 2.4k
J. Craske United Kingdom 17 237 0.4× 287 0.5× 727 1.4× 333 0.8× 136 0.4× 36 1.4k
Ethan Bornstein United States 9 1.7k 2.5× 2.1k 3.3× 879 1.6× 1.1k 2.6× 530 1.5× 9 3.4k

Countries citing papers authored by Bittoo Kanwar

Since Specialization
Citations

This map shows the geographic impact of Bittoo Kanwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bittoo Kanwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bittoo Kanwar more than expected).

Fields of papers citing papers by Bittoo Kanwar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bittoo Kanwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bittoo Kanwar. The network helps show where Bittoo Kanwar may publish in the future.

Co-authorship network of co-authors of Bittoo Kanwar

This figure shows the co-authorship network connecting the top 25 collaborators of Bittoo Kanwar. A scholar is included among the top collaborators of Bittoo Kanwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bittoo Kanwar. Bittoo Kanwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandborn, William J., Larry Mattheakis, Nishit B. Modi, et al.. (2021). PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. Gastroenterology. 161(6). 1853–1864.e10. 28 indexed citations
2.
Posch, Maximilian, Alina Jucov, Christian Geier, et al.. (2021). P294 AMT-101, a gut selective oral IL-10 fusion: results from a Phase 1b study in patients with active Ulcerative Colitis. Journal of Crohn s and Colitis. 15(Supplement_1). S324–S325. 1 indexed citations
3.
Mrsny, Randall J., Bittoo Kanwar, & Tahir Mahmood. (2020). OP39 Treatment of ulcerative colitis With AMT-101, a novel oral interleukin-10 immunomodulatory fusion biologic that traffics across the intestinal epithelium. Journal of Crohn s and Colitis. 14(Supplement_1). S039–S040. 3 indexed citations
4.
Campbell, Robert R., et al.. (2019). 751 Safety, Tolerability, and Pharmacokinetics of PTG-200, an Oral GI-Restricted Peptide Antagonist of IL-23 Receptor, in Normal Healthy Volunteers. The American Journal of Gastroenterology. 114(1). S439–S440. 14 indexed citations
5.
Onken, Jane E., Elizabeth H. Yen, Bittoo Kanwar, et al.. (2015). Tu2056 Safety and Efficacy of GS-5745 an Anti-Matrix Metalloproteinase 9 (MMP) Monoclonal Antibody in Patients With Moderately to Severely Active Ulcerative Colitis. Gastroenterology. 148(4). S–1196. 2 indexed citations
6.
Lowe, Margaret M., Jeff E. Mold, Bittoo Kanwar, et al.. (2014). Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production. PLoS ONE. 9(2). e87877–e87877. 106 indexed citations
7.
Wyles, David, M. Rodríguez‐Torres, Eric Lawitz, et al.. (2014). All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naïve Patients With Genotype 1 HCV Infection. Hepatology. 60(1). 56–64. 38 indexed citations
8.
Nyberg, Lisa M., Jacob Lalezari, Liyun Ni, et al.. (2014). 239 Successful Retreatment With Sofosbuvir-Containing Regimens for HCV Genotype 2 or 3 Infected Patients Who Failed Prior Sofosbuvir Plus Ribavirin Therapy. Gastroenterology. 146(5). S–905. 2 indexed citations
9.
Esteban, Rafael, Lisa M. Nyberg, Jacob Lalezari, et al.. (2014). O8 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR-CONTAINING REGIMENS FOR HCV GENOTYPE 2 OR 3 INFECTED PATIENTS WHO FAILED PRIOR SOFOSBUVIR PLUS RIBAVIRIN THERAPY. Journal of Hepatology. 60(1). S4–S5. 26 indexed citations
10.
11.
Everson, Gregory T., Adrian M. Di Bisceglie, Simon C. Ling, et al.. (2013). 13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION. Journal of Hepatology. 58. S6–S6. 10 indexed citations
12.
Hartigan-O’Connor, Dennis J., Kristina Abel, Koen K. A. Van Rompay, Bittoo Kanwar, & Joseph M. McCune. (2012). SIV Replication in the Infected Rhesus Macaque Is Limited by the Size of the Preexisting T H 17 Cell Compartment. Science Translational Medicine. 4(136). 136ra69–136ra69. 28 indexed citations
13.
Broadhurst, M. Jana, Amir Ardeshir, Bittoo Kanwar, et al.. (2012). Therapeutic Helminth Infection of Macaques with Idiopathic Chronic Diarrhea Alters the Inflammatory Signature and Mucosal Microbiota of the Colon. PLoS Pathogens. 8(11). e1003000–e1003000. 171 indexed citations
14.
Favre, David, Jeff E. Mold, Peter W. Hunt, et al.. (2010). Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T H 17 to Regulatory T Cells in HIV Disease. Science Translational Medicine. 2(32). 32ra36–32ra36. 423 indexed citations
15.
Kanwar, Bittoo, David Favre, & Joseph M. McCune. (2010). Th17 and regulatory T cells: implications for AIDS pathogenesis. Current Opinion in HIV and AIDS. 5(2). 151–157. 118 indexed citations
16.
Loke, P’ng, David Favre, Peter W. Hunt, et al.. (2010). Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. Blood. 115(15). e20–e32. 35 indexed citations
17.
Favre, David, Sharon Lederer, Bittoo Kanwar, et al.. (2009). Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection. PLoS Pathogens. 5(2). e1000295–e1000295. 307 indexed citations
18.
Cheng, Laurence E., Bittoo Kanwar, Haig Tcheurekdjian, et al.. (2009). Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clinical Immunology. 132(1). 124–131. 54 indexed citations
19.
Lederer, Sharon, David Favre, Kathie‐Anne Walters, et al.. (2009). Transcriptional Profiling in Pathogenic and Non-Pathogenic SIV Infections Reveals Significant Distinctions in Kinetics and Tissue Compartmentalization. PLoS Pathogens. 5(2). e1000296–e1000296. 103 indexed citations
20.
Kanwar, Bittoo, Dong Gao, Andrew B. Hwang, et al.. (2007). In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis. Journal of Immunological Methods. 329(1-2). 21–30. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Ferrando‐Martínez Breakdown of academic impact, for papers by Isabelle Garrigue Breakdown of academic impact, for papers by Gene M. Shearer Breakdown of academic impact, for papers by Giuseppe Nunnari Breakdown of academic impact, for papers by M. Leal Breakdown of academic impact, for papers by Alejandro Vallejo Breakdown of academic impact, for papers by Cara C. Wilson Breakdown of academic impact, for papers by Barry M. Bredt Breakdown of academic impact, for papers by J. Craske Breakdown of academic impact, for papers by Ethan Bornstein
Rankless by CCL
2026